Elizabeth P. Spencer, project manager and licensing officer for technology transfer atCarnegieMellonUniversity, has been named director of technology transfer for the University of Notre DamesGraduateSchool.
We are pleased and excited that Liz Spencer will be joining our Office of Research team,said Michael T. Edwards, assistant vice president and director of the Universitys Office of Research.Liz brings with her significant talents, skills and experience in both research and technology transfer. She should prove to be a valuable asset for our faculty and the University.
Spencer has worked in technology transfer and commercialization for more than 25 years. At Carnegie Mellon, she was responsible for evaluating faculty inventions for commercialization, coordinating patenting, marketing technologies, and negotiating licenses to existing companies and spin-offs.
Prior to her work at Carnegie Mellon, Spencer evaluated new biotechnologies for LaunchCyte LLC, a private, for-profit biotech incubator. Before that, she served as project manager with Demegen Inc., aPittsburghbiopharmaceutical company. She managed the daily activities of Demegens drug development projects, including sponsored research, grant writing, clinical trials and out-licensing efforts.
Spencer, who holds a bachelors degree from Carnegie Mellon and a masters degree from theUniversityofPittsburgh, also has worked in the research labs atHarvardMedicalSchool, Magee-Womens Hospital and theUniversityofPittsburgh.
She will assume her position Aug. 1.
TopicID: 12082